Arena Pharmaceuticals (ARNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Sales | 1,755 | 15,364 | 2,415 | 1,898 | 1,660 |
| Gross Profit | 1,755 | 15,364 | 2,415 | 1,898 | 1,660 |
| Operating Expenses | 32,724 | 28,964 | 36,626 | 24,850 | 22,864 |
| Operating Income | -30,969 | -13,600 | -34,211 | -22,952 | -21,204 |
| Interest Expense | 1,472 | 1,495 | 1,516 | 1,538 | 1,570 |
| Other Income | 1,308 | 825 | 457 | 727 | 223 |
| Pre-tax Income | -31,133 | -14,270 | -35,270 | -23,763 | -22,551 |
| Net Income Continuous | -31,133 | -14,270 | -35,270 | -23,763 | -22,551 |
| Net Income Discontinuous | -830 | 315 | 2,606 | 147 | 54 |
| Minority Interests | N/A | -271 | -311 | -299 | -444 |
| Net Income | $-31,963 | $-13,684 | $-32,353 | $-23,317 | $-22,053 |
| EPS Basic Total Ops | -0.80 | -0.24 | -0.86 | -0.77 | -0.90 |
| EPS Basic Continuous Ops | -0.78 | -0.27 | -0.93 | -0.77 | -0.90 |
| EPS Basic Discontinuous Ops | -0.02 | 0.02 | 0.07 | 0.00 | 0.00 |
| EPS Diluted Total Ops | -0.80 | -0.24 | -0.86 | -0.77 | -0.90 |
| EPS Diluted Continuous Ops | -0.78 | -0.27 | -0.93 | -0.77 | -0.90 |
| EPS Diluted Discontinuous Ops | -0.02 | 0.02 | 0.07 | 0.00 | 0.00 |
| EBITDA(a) | $-30,164 | $-12,522 | $-33,133 | $-21,838 | $-20,060 |